Severe Hypoglycaemia Leading to Hospital Admission in Type 2 Diabetic Patients Aged 80 Years or Older

 

 Buy Article Permissions and Reprints

Abstract

Aim: Evidence is mounting that hypoglycaemia among elderly diabetic patients is a very real and costly concern. Objective of this study was to determine the incidence and risk factors for developing severe hypoglycaemia leading to hospital admission, among type 2 diabetic subjects aged 80 years or older.

Methods: Hypoglycaemia was defined as a symptomatic event requiring treatment with i. v. glucose and confirmed by a blood glucose determination <50 mg/dl.

Results: During a eight-year period severe hypoglycaemia was identified in 99 subjects. These patients were found to have a reduced cognitive ability, a heavy burden of comorbid disease and a HbA1c values of 5.9%. Of the hypoglycaemic episodes, 76 occurred in patients taking glibenclamide. Diabetes therapy was prescribed by general practitioners in 85 of them. Only 26 patients performed regular home blood glucose self-monitoring.

Conclusion: Severe hypoglycaemia is a serious and not uncommon metabolic emergency among patients with type 2 diabetes aged 80 years or older; it is more frequent in patients with considerable comorbidity undergoing aggressive diabetes management and in users of a long-acting sulphonylurea. In elderly subject, each patient's risk for hypoglycaemia should be considered and therapy should be individualized accordingly; in our opinion, a great number of episodes may be avoided by teaching the principles of blood glucose monitoring and involving general practitioners in outpatients management of diabetes mellitus.

References

• 1 Allicar M, Megas F, Houzard S. et al . Frequency and costs of hospital stays for hypoglycemia in France in 1995.  Presse Med. 2000;  29 837-853
  Google Scholar
• 2 Amiel SA, Dixon T, Mann R. et al . Hypoglycaemia in type 2 diabetes.  Diabet Med. 2008;  25 245-254
  Google Scholar
• 3 Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases.  Diabetologia. 1983;  24 412-417
  Google Scholar
• 4 Baxter MA. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.  Acta Diabetol. 2008;  45 253-268
  Google Scholar
• 5 Ben-Ami H, Nagachandran P, Mendelson A. et al . Drug-induced hypoglycemic coma in 102 diabetic patients.  Arch Intern Med. 1999;  159 281-284
  Google Scholar
• 6 Biessels GJ, Staekenborg S, Brunner E. et al . Risk of dementia in diabetes mellitus: a systematic review.  Lancet Neurol. 2006;  5 64-74
  Google Scholar
• 7 Chau D, Edelman SV. Clinical management of diabetes in the elderly.  Clinical Diabetes. 2001;  19 172-175
  Google Scholar
• 8 Chelliah A, Burge MR. Hypoglycaemia in elderly patients with diabetes mellitus.  Drugs Aging. 2004;  21 511-530
  Google Scholar
• 9 Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
  Google Scholar
• 10 Culy CR, Jarvis B. Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.  Drugs. 2001;  61 1625-1660
  Google Scholar
• 11 Gangji AS, Goldsmith CH, Cukierman T. et al . A systematic review and meta-analysis of hypoglycemia and cardiovascular events.  Diabetes Care. 2007;  30 389-394
  Google Scholar
• 12 Greco D, Angileri G. Drug-induced severe hypoglycemia in type 2 diabetic patients aged 80 years or older.  Diab Nutr Metab. 2004;  17 23-26
  Google Scholar
• 13 Holstein A, Plaschke A, Eick-Hartwig E. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.  Diabetes Metab Res Rev. 2001;  17 467-473
  Google Scholar
• 14 Holstein A, Plaschke A, Egberts EH. Incidence and costs of severe hypoglycaemia.  Diabetes Care. 2002;  25 2109-2110
  Google Scholar
• 15 Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia: a prospective population-based study.  Exp Clin Endocrinol Diabetes. 2003;  111 364-369
  Google Scholar
• 16 Holstein A, Egberts EH. Risk of hypoglycaemia with oral antidiabetic agents in patients with type 2 diabetes.  Exp Clin Endocrinol Diabetes. 2003;  111 405-414
  Google Scholar
• 17 Jaap AJ, Jones GC, McCrimman RJ. et al . Perceived symptoms of hypoglycaemia in type 2 diabetic patients treated with insulin.  Diabet Med. 1988;  15 398-401
  Google Scholar
• 18 Lardinois CK. Type 2 diabetes: glycemic targets and oral therapies for older patients.  Geriatrics. 1998;  53 22-28
  Google Scholar
• 19 McAulay V, Frier BM. Insulin analogues and other development in insulin therapy for diabetes.  Expert Opin Pharmaco-Ther. 2003;  4 1141-1156
  Google Scholar
• 20 Mutch WJ, Dingwall-Fordyce I. Is it a hypo? Knowledge of the symptoms of hypoglycaemia in elderly diabetic patients.  Diabet Med. 1985;  2 54-56
  Google Scholar
• 21 Nattras M, Lauritzen T. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of type 2 diabetes?.  Int J Obesity. 2000;  24 ((Suppl. 3)) S21-S31
  Google Scholar
• 22 Pegg A, Fitzgerald D, Wise D. et al . A community-based study of diabetes-related skills and knowledge in elderly people with insulin-requiring diabetes.  Diabet Med. 1991;  8 778-781
  Google Scholar
• 23 Rosenstock J. Management of type 2 diabetes mellitus in the elderly. Special considerations.  Drugs Aging. 2001;  18 31-40
  Google Scholar
• 24 Seltzer HS. Drug-induced hypoglycemia: a review of 1418 cases.  Endocrinol Metab Clin North Am. 1999;  18 163-183
  Google Scholar
• 25 Shorr RI, Ray WA, Daugherty JR. et al . Individual sulfonylureas and serious hypoglycemia in older people.  J Am Geriatr Soc. 1996;  44 871-872
  Google Scholar
• 26 Shorr RI, Ray WA, Daugherty JR. et al . Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.  Arch Intern Med. 1997;  157 1681-1686
  Google Scholar
• 27 Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.  Diabet Med. 1999;  16 586-590
  Google Scholar
• 28 Thomson FJ, Masson EA, Leeming JT. et al . Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients.  Age Ageing. 1991;  20 404-406
  Google Scholar
• 29 van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas.  J Clin Epidemiol. 1997;  50 735-741
  Google Scholar
• 30 Whitmer RA, Karter AJ, Yaffe K. et al . Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.  JAMA. 2009;  301 1565-1572
  Google Scholar
• 31 Zammitt NN, Frier BM. Hypoglycaemia in type 2 diabetes.  Diabetes Care. 2005;  28 2948-2961
  Google Scholar

Correspondence

Dr. D. Greco

Via Cosenza 155

91016 Erice (TP)

Phone: +39/092/378 23 04

Fax: +39/092/378 23 03

Email: drgreco@alice.it